SORCS2 is associated with increased risk of AD, declined cognitive function and altered amyloid precursor protein (APP) processing [84] and MMP2 is a matrix metalloproteinase that degrades extracellular Aβ. The gene discussed is APP; the disease is Alzheimer disease.